Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

GW Pharmaceuticals plc  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Jazz Pharmaceuticals plc for $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS).  

Viela Bio, Inc.  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Horizon Therapeutics plc for $53.00 per share in cash. 

FLIR Systems, Inc.  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Teledyne Technologies Incorporated for $28.00 per share in cash and 0.0718 shares of Teledyne common stock for each FLIR share. 

Seneca Biopharma, Inc.  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Leading BioSciences, Inc.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

See Campaign: https://www.halpersadeh.com
Contact Information:
zhalper@halpersadeh.com 

Tags:
, Wire, Legal Newswire, United States, English